Difference between revisions of "Renal Oncocytoma"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 59: | Line 59: | ||
Write your comments here | Write your comments here | ||
| − | == | + | == Therapeutics == |
Write your comments here | Write your comments here | ||
| Line 66: | Line 66: | ||
Write your comments here | Write your comments here | ||
| + | |||
| + | ==References== | ||
| + | {{Reflist}} | ||
Revision as of 20:18, 12 February 2016
Contributors
Write your comments here
Tumor Type
Write your comments here
Tumor Classification
Write your comments here
Description
Write your comments here
IHC Markers
Write your comments here
Genomic Gain/Loss/LOH
Write your comments here
Rearrangements
Write your comments here
Mutations (SNV/INDEL)
Write your comments here
From Cosmic Mutated in >20%
Mutated in 10-20%
Mutated in 5-10%
Mutated in 2-5%
mtDNA
Epigenomics (methylation)
Write your comments here
Main Pathways Involved
Write your comments here
Clinical Significance
Write your comments here
Diagnosis
Write your comments here
Prognosis
Write your comments here
Therapeutics
Write your comments here
Familial Forms
Write your comments here